APA (7th ed.) Citation

SS, D., F, M., M, N., LB, O., T, B., A, P., . . . ML, H. (2022). Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis: A nationwide nested case-control study. RMD open, 8(2), . https://doi.org/10.1136/rmdopen-2022-002636

Chicago Style (17th ed.) Citation

SS, Dieperink, Mehnert F, Nørgaard M, Oestergaard LB, Benfield T, Petersen A, Torp-Pedersen C, Glintborg B, and Hetland ML. "Antirheumatic Treatment, Disease Activity and Risk of Staphylococcus Aureus Bacteraemia in Rheumatoid Arthritis: A Nationwide Nested Case-control Study." RMD Open 8, no. 2 (2022). https://doi.org/10.1136/rmdopen-2022-002636.

MLA (9th ed.) Citation

SS, Dieperink, et al. "Antirheumatic Treatment, Disease Activity and Risk of Staphylococcus Aureus Bacteraemia in Rheumatoid Arthritis: A Nationwide Nested Case-control Study." RMD Open, vol. 8, no. 2, 2022, https://doi.org/10.1136/rmdopen-2022-002636.